CFDE Data Portal | Search CLLU1-AS1

	Label	Description
	CLLU1-AS1 Gene (Entity type)	ENSG00000205057 - CLLU1 antisense RNA 1
	GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 11 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206927 PPARG knockdown endothelial cell 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216757 decitabine fibroblast 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx SmallIntestine 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SalivaryGland 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Blood 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx

CLLU1-AS1

ENSG00000205057 - CLLU1 antisense RNA 1

GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up

A Gene Set from LINCS

GSE48812 sulforaphane 11 v 1 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 2 v 4 human up

A Gene Set from LINCS

GSE206927 PPARG knockdown endothelial cell 1 v 3 human up

A Gene Set from LINCS

GSE216757 decitabine fibroblast 0 v 1 human up

A Gene Set from LINCS

GSE172494 nicotinamide 2 v 1 human dn

A Gene Set from LINCS

GTEx SmallIntestine 20-29 vs 60-69 Down

A Gene Set from GTEx

GTEx SalivaryGland 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Blood 20-29 vs 30-39 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.